News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Daily News More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin L.A. McKeown February 14, 2025
News Daily News CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy Todd Neale December 04, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Daily News Hormonal Birth Control, NSAID Use Together Linked to VTE Caitlin E. Cox September 11, 2023
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Daily News Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis L.A. McKeown February 02, 2023
News Daily News PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures L.A. McKeown January 18, 2023
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Conference News AHA 2022 ‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge L.A. McKeown November 11, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022